Summary
Lots
1 lot
Awards
0 awards
Awarded suppliers
0
awarded suppliers
Documents
3 documents
Notice history
1 notice
Received offers
Not provided
Integrity signals
15 · LowAutomated screening based on procurement documents and award history. Findings are only shown here once a human reviewer has confirmed them; this is not an allegation of wrongdoing.
-
Specification
· High
The specification mandates a specific combination of three bacterial strains at a precise concentration (1.2x10^7 CFU). This combination and concentration are characteristic of a single proprietary product (e.g., Linex), effectively excluding other probiotic formulations that may be clinically equivalent but contain different strains or concentrations.
-
Enterococcus faecium/Lactobacillus acidophilus/Bifidobacterium infantis, kapsula, satur ne mazāk kā 1.2x10*7 KVV liofilizētu dzīvotspējīgu pienskābo baktēriju
-
Procurement facts
Procurement id
8c920d02-0f3d-49c5-9694-fe27f2d068f2
Procedure
open
Legal basis
pil-over
Main nature
supplies
Main CPV
33690000-3
Values and statistics
Estimated value
3,500,000.00 EUR
Contract value
Not provided
Received offers
Not provided
Lots
1
Authority
Registration
42103041306
Country
LVA
No award data available.
Lots
1 lot| Lot | Place and duration | Estimated value | Result |
|---|---|---|---|
| Lot 1 | LVA | 3,500,000.00 EUR | Not provided |
Documents
3 documents| Document | Type and metadata | Link |
|---|---|---|
| Procurement documents | documents_url | Open document |
| Noslēguma ziņojums_LRS_2026_5.docx | docx | Open document |
| Noslēguma ziņojums_LRS_2026_5_piel1.xlsx | xlsx | Open document |
Notice history
1 notice| Notice | Type and form | Date |
|---|---|---|
| da4e8e81-6c5c-48ab-a40c-deb7df571303 | pil-contract | 2026-02-01 |